Cardiovascular disease mortality after chemotherapy or surgery for testicular nonseminoma: a population-based study

C Fung, SD Fossa, MT Milano… - Journal of Clinical …, 2015 - ascopubs.org
Purpose Increased risks of incident cardiovascular disease (CVD) in patients with testicular
cancer (TC) given chemotherapy in European studies were largely restricted to long-term …

Preferred treatment for stage I seminoma: a survey of Canadian radiation oncologists

RA Huddart, JK Joffe - Clinical Oncology, 2006 - clinicaloncologyonline.net
About one-half of all patients with testicular germ cell tumours present with a seminoma. Of
these, about 85% present with stage I disease. Numerically, therefore, stage I seminoma …

Stage I seminoma: What should a practicing uro‐oncologist do in 2009?

J Skliarenko, D Vesprini… - International journal of …, 2009 - Wiley Online Library
Testicular tumors are uncommon, but they continue to represent an important group of
malignancies in young men. It is the most common solid malignancy in males between the …

Adverse prognostic factors for testicular cancer–specific survival: a population-based study of 27,948 patients

SD Fosså, M Cvancarova, L Chen, AL Allan… - Journal of Clinical …, 2011 - ascopubs.org
Purpose The prognostic significance of age at testicular cancer (TC) diagnosis,
socioeconomic status (SES), race, and marital status on TC-specific mortality is not well …

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

RTD Oliver, PM Edmonds, JYH Ong… - International Journal of …, 1994 - Elsevier
Purpose: Underpinned by increased confidence in cure of metastatic seminoma by
chemotherapy during the past 12 years, three management strategies for Stage I seminoma …

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

RTD Oliver, MD Mason, GM Mead, H von der Maase… - The Lancet, 2005 - thelancet.com
Background Adjuvant radiotherapy is effective treatment for stage I seminoma, but is
associated with a risk of late non-germ-cell cancer and cardiovascular events. After good …

The preferred treatment for stage I seminoma: a survey of Canadian radiation oncologists

I Alomary, R Samant, P Genest, L Eapen, V Gallant - Clinical Oncology, 2006 - Elsevier
AIMS: To evaluate the preferences of radiation oncologists for managing stage I seminoma.
MATERIALS AND METHODS: An electronic survey evaluating the management of stage I …

[引用][C] Management of stage I seminoma: Guideline recommendations

P Chung, LA Mayhew, P Warde, E Winquist, H Lukka… - Program in Evidence-Based …, 2008

[HTML][HTML] Treatment options in stage I seminoma

U Bumbasirevic, M Zivkovic, M Petrovic, V Coric… - Oncology …, 2022 - ncbi.nlm.nih.gov
Seminomas are most commonly diagnosed in clinical stage I (CSI). After orchiectomy,
approximately 15% of patients in this stage have subclinical metastases. Adjuvant …

Sociodemographic and provider based disparities in the management of stage I testicular cancer

G Agarwal, P Sharma, O Valderrama, HY Lin… - Urology …, 2017 - auajournals.org
Introduction: The treatment paradigm for stage I testicular cancer has changed in the setting
of accurate staging, reliable followup and a greater understanding of treatment related side …